Heart Failure Clinical Trial
Financial Support in an Underserved and Low-Income Population With Heart Failure
The goal of this clinical trial is to test whether financial support in the form of a one-time $500 stipend would improve medication adherence and quality of life in low-income, socially-needy patients with heart failure with reduced ejection fraction in the post-discharge setting. The main questions it aims to answer are:
Will financial support improve medication adherence?
Will financial support improve heart failure quality of life?
Participants will complete surveys on quality of life, social stress, and spending habits at their baseline visit. Participants will be randomly assigned to receive $500 at their baseline visit or $0 at their baseline visit. At their one month visit, medication adherence and quality of life will be assessed. These results will be compared between groups. The group that received $0 at their baseline visit will be provided $500 at their one-month visit and return for a two-month visit. At that visit, medication adherence and quality of life will be assessed. These results will be compared to their one-month results.
Researchers will compare the 1-month medication adherence and quality of life scores between the immediate financial support vs delayed financial support. Researchers will also compare 1-month vs 2-month adherence and quality of life data for participants who were randomized to the delayed financial support group.
Age > 18
English speaking participants who completed SOCIAL-HF study surveys
Ejection Fraction <=40% and eligible for at least one component of GDMT
Has at least some difficulty paying monthly bills (Somewhat Difficult and Very Difficult)
Annual household income <130% Federal Poverty Limit
Have at least two additional social needs based on the following domains:
Household Crowding: Person/Room Ratio >1
Rent Burden: Rent/Income Ratio >30%
Low social support
History of Discrimination
Unwilling to return for 1 and 2-month follow-up visits.
Currently in jail or prison
Primary residence outside Dallas County
Systolic blood pressure <90 mmHg on screening
Contraindications or Intolerance all medications available for therapeutic drug monitoring (metoprolol, losartan, lisinopril, valsartan, and spironolactone)
Unable to answer orientation questions.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.